<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230504058069N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-06-18</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>ًRTMS effects on PSP patients</public_title>
      <acronym></acronym>
      <scientific_title>Effect of repetitive transcranial magnetic stimulation on dysarthria and postural disturbance in patients with progressive supranuclear palsy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-05-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>12</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/70086</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: there was used randominaztion techniques by blocks for patients' groups randominazation, for this purpose we must make a block by 30 charachters with combination of A ,B alphabet in "sealed envelope" site and use it for randominazation.
we use allocation concealment by sealed envelops, Blinding description: blinding was done in participant patients,investigators and outcome assesors.patients and investigators by using a secret code in the selead envelopes remain blinded and information analizer is chosen from out of researcher group
Intervention patient (receive RTMS or sham) in sealed envelopes that code
are received. Coding by one of the project collaborators
It takes place and the doctor, evaluator and patient are blinded.</study_design>
      <phase>N/A</phase>
      <hc_freetext>PSP Proressive supranuclear palsy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: 6 PSP patients who receive 10 sessions of rTMS with 900 daily pulses of 10 Hz every other day. The location of the coils will be in contact with the skull two centimeters on the sides and one centimeter below the inion. Intervention 2: Control group: 6 PSP patients who receive 10 sessions of rTMS  every other day ,along with a 3 cm non-conductive object between the scalp and the cap of the device and 900 daily pulses of 10 Hz. The location of the coils will be in contact with the skull two centimeters on the sides and one centimeter below the inion.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All the potential data of movement score and questionnaires and speech and swallowing scores of patients can be shared after making them non-identifiable

When:
Access starts 6 months to a year after publication

To whom:
only available for people working in academic institutions

Conditions:
It is possible to use the documents of this research only by mentioning the names of its researchers in articles and academic researches.

Where to obtain:
from responsible author: Mina Farah Nejad
Email: m.farahnezhad@yahoo.com and  farahnezhadm991@mums.ac.ir
Phone number: 00989127635742

How to obtain:
After requesting to receive the research documents by the researcher's academic email and after explaining about the research and the reason for the need of the desired documents by sending to the responsible author's email, if accepted, it will be sent within 1 month at the latest

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mina FarahNezhad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 303,Eastern Wing, Third Floor,Tower G, Tower G4,before Kharazi Highway,Northern Pazhouhesh Blvd,Chitgar,Tehran</address>
        <city>mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1496960720</zip>
        <telephone>+98 912 763 5742</telephone>
        <email>m.farahnezhad@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>mina farahnezhad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 303, Third Floor,Eastern Wing,Tower G4,G Towers,before Kharazi Highway,Northern pazhouhesh Blvd.,Chitgar,Tehran</address>
        <city>mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1496960720</zip>
        <telephone>+98 912 763 5742</telephone>
        <email>m.farahnezhad@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>PSP patients that was diagnosed by national institute of neurologic disease and stroke for PSP citeria
patient who can stand alon and without helping
patient who can walking at least a few steps without helping
patient who can speak and answer the questions
patient who has signed the informed consent form to enter the plan</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>patient who was diagnosed dementia by DSM-IV criteria
patient who had vestibular or properioception or sensory deficits
patient who has any contraindication of brain stimulation (such as pacemakers or presence of metal objects in the head)
the patient had dysartheria before the onset of disease
patient who had past medical history of stroke
patient who is mute</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G23.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: 6 PSP patients who receive 10 sessions of rTMS with 900 daily pulses of 10 Hz every other day. The location of the coils will be in contact with the skull two centimeters on the sides and one centimeter below the inion</i_keyword>
      <i_keyword>Control group: 6 PSP patients who receive 10 sessions of rTMS  every other day ,along with a 3 cm non-conductive object between the scalp and the cap of the device and 900 daily pulses of 10 Hz. The location of the coils will be in contact with the skull two centimeters on the sides and one centimeter below the inion.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Checking the postural instabilility of patients. Timepoint: The beginning of the study (before starting rTMS), the end of receiving rTMS, four months later. Method of measurement: Kinematic analysis of scoring movement based on the results of forces and energy.</prim_outcome>
      <prim_outcome>Checking the speech and swalling of patients. Timepoint: The beginning of the study (before starting rTMS), the end of receiving rTMS, four months later. Method of measurement: Wanberg's auditory-perceptual assessment index and the Northwestern swallowing disorder test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>کیفیت زندگی بیماران. Timepoint: The beginning of the study and the end of the study. Method of measurement: PDQL questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-11-08</approval_date>
        <contact_name>Research Ethics committees of school of medicine-Mashhad university of medical sciences</contact_name>
        <contact_address>Research and Technology Vice-Chancellor, Qurashi Building, next to Hoize Cinema,University St.,Mashhad Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
